Hannsjörg W Seyberth Selected Research

Bartter Syndrome (Syndrome, Bartter)

1/2017	Bartter's and Gitelman's syndrome.
5/2016	Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations.
10/2008	An improved terminology and classification of Bartter-like syndromes.
8/2006	Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter.
8/2005	Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
11/2004	Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the serum- and glucocorticoid-dependent kinases.
2/2004	Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies.
7/2002	Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.
6/2002	Barttin increases surface expression and changes current properties of ClC-K channels.
8/2000	Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hannsjörg W Seyberth Research Topics

Disease

10	Bartter Syndrome (Syndrome, Bartter) 01/2017 - 08/2000
5	Deafness (Deaf Mutism) 01/2011 - 06/2002
3	Polyuria 05/2016 - 11/2005
3	Hypercalciuria 03/2016 - 12/2001
3	Hypokalemia 03/2016 - 04/2005
3	Alkalosis 08/2006 - 08/2000
3	Nephrocalcinosis 08/2006 - 08/2000
2	Gitelman Syndrome 01/2017 - 01/2004
1	Melanoma (Melanoma, Malignant) 05/2016
1	Hyperaldosteronism (Conn Syndrome) 10/2011
1	Polyhydramnios 08/2006
1	Hypovolemia 08/2006
1	Hyperuricemia 08/2006
1	Acute Kidney Injury (Acute Renal Failure) 11/2005
1	Dent Disease 07/2005
1	Osteoarthritis 06/2004
1	Nephrogenic Diabetes Insipidus 04/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2001

Drug/Important Bio-Agent (IBA)

18	SaltsIBA 01/2017 - 08/2000
5	MagnesiumIBA 03/2016 - 09/2001
2	Furosemide (Lasix)FDA LinkGeneric 08/2006 - 08/2005
2	Sodium Chloride FDA LinkGeneric 08/2006 - 06/2002
2	Chloride Channels (Chloride Channel)IBA 03/2004 - 08/2000
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2004 - 07/2002
2	CalciumIBA 02/2002 - 12/2001
1	AntigensIBA 05/2016
1	ChloridesIBA 08/2006
1	PotassiumIBA 08/2006
1	Potassium Chloride FDA LinkGeneric 08/2006
1	SodiumIBA 08/2006
1	SymportersIBA 08/2006
1	ProstaglandinsIBA 11/2005
1	Indomethacin (Indometacin)FDA LinkGeneric 11/2005
1	Prostaglandins EIBA 11/2005
1	Dinoprostone (PGE2)FDA Link 08/2005
1	CLC-5 chloride channelIBA 07/2005
1	EnzymesIBA 06/2004
1	ReninIBA 02/2004
1	Sodium Chloride SymportersIBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 06/2002
1	Aquaporin 2IBA 04/2002
1	Vasopressins (Vasopressin)IBA 04/2002
1	ThiazidesIBA 09/2001